$IAS
INTEGRAL AD SCIENCE HOLDING CORP.

2021 Q4 Form 10-Q Financial Statement

#000184271821000009 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $102.5M $79.01M $59.96M
YoY Change 31.77%
Cost Of Revenue $16.38M $13.85M
YoY Change
Gross Profit $86.09M $65.17M
YoY Change
Gross Profit Margin 84.01% 82.48%
Selling, General & Admin $44.98M $35.66M $20.38M
YoY Change 74.97%
% of Gross Profit 52.25% 54.72%
Research & Development $19.47M $14.61M $11.11M
YoY Change 31.53%
% of Gross Profit 22.61% 22.42%
Depreciation & Amortization $17.19M $418.0K $733.0K
YoY Change -65.19% -42.97%
% of Gross Profit 19.96% 0.64%
Operating Expenses $81.63M $50.27M $31.49M
YoY Change 59.65%
Operating Profit $4.459M -$1.204M $1.861M
YoY Change -164.7%
Interest Expense -$1.364M $5.753M $7.795M
YoY Change -26.2%
% of Operating Profit -30.59% 418.86%
Other Income/Expense, Net
YoY Change
Pretax Income -$3.505M -$10.68M
YoY Change
Income Tax $1.317M -$898.0K -$1.486M
% Of Pretax Income
Net Earnings -$4.822M -$9.780M -$4.448M
YoY Change 119.87%
Net Earnings / Revenue -4.71% -12.38% -7.42%
Basic Earnings Per Share -$0.06 -$0.03
Diluted Earnings Per Share -$31.29K -$0.06 -$0.03
COMMON SHARES
Basic Shares Outstanding 153.9M shares 152.0M shares 134.0M shares
Diluted Shares Outstanding 152.0M shares 134.0M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.21M $63.78M
YoY Change
Cash & Equivalents $73.21M $63.78M $38.07M
Short-Term Investments
Other Short-Term Assets $7.702M $10.37M
YoY Change
Inventory
Prepaid Expenses
Receivables $53.03M $45.59M
Other Receivables $36.23M $27.13M
Total Short-Term Assets $170.2M $146.9M
YoY Change 31.38%
LONG-TERM ASSETS
Property, Plant & Equipment $1.413M $1.417M
YoY Change -37.0%
Goodwill $676.5M $649.8M
YoY Change 47.52%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.143M $4.010M
YoY Change 16.47%
Total Long-Term Assets $959.4M $938.0M
YoY Change 33.24%
TOTAL ASSETS
Total Short-Term Assets $170.2M $146.9M
Total Long-Term Assets $959.4M $938.0M
Total Assets $1.130B $1.085B
YoY Change 32.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.307M $9.700M
YoY Change -5.69%
Accrued Expenses $39.90M $26.94M
YoY Change
Deferred Revenue $160.0K $568.0K
YoY Change -86.01%
Short-Term Debt $1.976M $0.00
YoY Change
Long-Term Debt Due $0.00 $50.00K
YoY Change
Total Short-Term Liabilities $56.49M $43.78M
YoY Change 39.8%
LONG-TERM LIABILITIES
Long-Term Debt $242.8M $232.7M
YoY Change -30.84%
Other Long-Term Liabilities $8.681M $1.754M
YoY Change
Total Long-Term Liabilities $251.5M $232.7M
YoY Change -28.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $56.49M $43.78M
Total Long-Term Liabilities $251.5M $232.7M
Total Liabilities $362.3M $331.3M
YoY Change -13.33%
SHAREHOLDERS EQUITY
Retained Earnings -$14.60M -$9.780M
YoY Change -88.48%
Common Stock $154.0K $154.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $767.2M $753.6M $425.2M
YoY Change
Total Liabilities & Shareholders Equity $1.130B $1.085B
YoY Change 32.95%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$4.822M -$9.780M -$4.448M
YoY Change 119.87%
Depreciation, Depletion And Amortization $17.19M $418.0K $733.0K
YoY Change -65.19% -42.97%
Cash From Operating Activities $25.94M $4.600M
YoY Change -20.26%
INVESTING ACTIVITIES
Capital Expenditures -$3.010M -$2.551M
YoY Change -36.8%
Acquisitions
YoY Change
Other Investing Activities -$20.23M -$166.2M
YoY Change
Cash From Investing Activities -$23.24M -$168.8M
YoY Change 387.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.983M 156.3M
YoY Change -744.19%
NET CHANGE
Cash From Operating Activities 25.94M 4.600M
Cash From Investing Activities -23.24M -168.8M
Cash From Financing Activities 6.983M 156.3M
Net Change In Cash 9.681M -7.833M
YoY Change -63.72%
FREE CASH FLOW
Cash From Operating Activities $25.94M $4.600M
Capital Expenditures -$3.010M -$2.551M
Free Cash Flow $28.95M $7.151M
YoY Change -22.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10014
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45418000 USD
dei City Area Code
CityAreaCode
646
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001842718
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40557
dei Entity Registrant Name
EntityRegistrantName
INTEGRAL AD SCIENCE HOLDING CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-0731995
dei Entity Address Address Line1
EntityAddressAddressLine1
95 Morton St.,
dei Entity Address Address Line2
EntityAddressAddressLine2
8th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York,
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Local Phone Number
LocalPhoneNumber
278-4871
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
IAS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
153940553 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63777000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51734000 USD
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
213000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
187000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45589000 USD
CY2021Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
27128000 USD
CY2020Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
28083000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10154000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4101000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
146861000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
129523000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1417000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2243000 USD
CY2021Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
17511000 USD
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
12322000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
265303000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
243348000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
649780000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
458586000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4010000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3557000 USD
CY2021Q3 us-gaap Assets
Assets
1084882000 USD
CY2020Q4 us-gaap Assets
Assets
849579000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43099000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
38789000 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
62000 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
150000 USD
CY2021Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
50000 USD
CY2020Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
325000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
568000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1144000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
43779000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40408000 USD
CY2021Q3 us-gaap Accrued Rent Noncurrent
AccruedRentNoncurrent
1754000 USD
CY2020Q4 us-gaap Accrued Rent Noncurrent
AccruedRentNoncurrent
1827000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
53035000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24794000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
232682000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
351071000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
331250000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
418100000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 ias Common Unit Par Value
CommonUnitParValue
4.1322314
CY2021Q3 ias Common Unit Par Value
CommonUnitParValue
4.1322314
CY2021Q3 us-gaap Common Unit Authorized
CommonUnitAuthorized
0 shares
CY2020Q4 us-gaap Common Unit Authorized
CommonUnitAuthorized
0 shares
CY2021Q3 us-gaap Common Unit Outstanding
CommonUnitOutstanding
0 shares
CY2021Q3 us-gaap Common Unit Issued
CommonUnitIssued
0 shares
CY2020Q4 us-gaap Common Unit Outstanding
CommonUnitOutstanding
134039494 shares
CY2020Q4 us-gaap Common Unit Issued
CommonUnitIssued
134039494 shares
CY2021Q3 us-gaap Common Unit Issuance Value
CommonUnitIssuanceValue
0 USD
CY2020Q4 us-gaap Common Unit Issuance Value
CommonUnitIssuanceValue
553717000 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
153940553 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
153940553 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
154000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
762470000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
788000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4523000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9780000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-126761000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
753632000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
431479000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1084882000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
849579000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
79014000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59964000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
221041000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
162326000 USD
CY2021Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
13846000 USD
CY2020Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
10180000 USD
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
38191000 USD
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
28091000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19574000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13519000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
63387000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
48643000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14609000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11107000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47554000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36169000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16089000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6863000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
57680000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22449000 USD
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16100000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16434000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
45098000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
49185000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
80218000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
58103000 USD
us-gaap Costs And Expenses
CostsAndExpenses
251910000 USD
us-gaap Costs And Expenses
CostsAndExpenses
184537000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1204000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1861000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-30869000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-22211000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
5753000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
7795000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-52470000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-45959000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-898000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1486000 USD
us-gaap Interest Expense
InterestExpense
17880000 USD
us-gaap Interest Expense
InterestExpense
23748000 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3721000 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3721000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-10678000 USD
CY2020Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-5934000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4855000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10616000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9780000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4448000 USD
us-gaap Net Income Loss
NetIncomeLoss
-47615000 USD
us-gaap Net Income Loss
NetIncomeLoss
-35343000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151988054 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151988054 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134039202 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134039202 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140016260 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140016260 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134047188 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134047188 shares
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2549000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1761000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3735000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1037000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12329000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2687000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51350000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34306000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
433839000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
150000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7984000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2549000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9780000 USD
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
274357000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
49631000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
753632000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
431479000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1204000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4435000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3735000 USD
ias Net Income Loss Prior To Corporate Conversion
NetIncomeLossPriorToCorporateConversion
-37832000 USD
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46132000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
150000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
274357000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
49631000 USD
ias Net Income Loss After Corporate Conversion
NetIncomeLossAfterCorporateConversion
-9780000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
753632000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
427957000 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
71000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1761000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4448000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
425199000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
459672000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
167000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1037000 USD
us-gaap Net Income Loss
NetIncomeLoss
-35343000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
425199000 USD
us-gaap Net Income Loss
NetIncomeLoss
-47615000 USD
us-gaap Net Income Loss
NetIncomeLoss
-35343000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
45098000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
49185000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
49673000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9966000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12431000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3721000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1020000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1024000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
764000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1647000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
394000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
3351000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-774000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2581000 USD
ias Increase Decrease In Unbilled Receivable
IncreaseDecreaseInUnbilledReceivable
-703000 USD
ias Increase Decrease In Unbilled Receivable
IncreaseDecreaseInUnbilledReceivable
-1542000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6151000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
86000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
574000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-81000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
220000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6644000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-62000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-587000 USD
ias Increase Decrease In Accrued Rent
IncreaseDecreaseInAccruedRent
220000 USD
ias Increase Decrease In Accrued Rent
IncreaseDecreaseInAccruedRent
162000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-563000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1112000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37656000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16659000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
166204000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
636000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
447000 USD
us-gaap Payments For Software
PaymentsForSoftware
10011000 USD
us-gaap Payments For Software
PaymentsForSoftware
7568000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-176851000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8015000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
281589000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4728000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
355934000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
235000000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2318000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
275000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1333000 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
1202000 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
167000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1075000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
153207000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1500000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14012000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7144000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2042000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54721000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30370000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66691000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38065000 USD
us-gaap Interest Paid Net
InterestPaidNet
17109000 USD
us-gaap Interest Paid Net
InterestPaidNet
15224000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1438000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
674000 USD
ias Deferred Offering Costs Accrued Not Yet Paid
DeferredOfferingCostsAccruedNotYetPaid
2506000 USD
ias Deferred Offering Costs Accrued Not Yet Paid
DeferredOfferingCostsAccruedNotYetPaid
0 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
212000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
11000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
88000 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
682000 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
894000 USD
ias Conversion Of Members Equity To Additional Paid In Capital
ConversionOfMembersEquityToAdditionalPaidInCapital
165385000 USD
ias Conversion Of Members Equity To Additional Paid In Capital
ConversionOfMembersEquityToAdditionalPaidInCapital
0 USD
us-gaap Use Of Estimates
UseOfEstimates
Use of estimates<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates include the allocation of purchase price consideration in the business combination and the related valuation of acquired assets and liabilities, the estimated useful lives of our property and equipment, intangible assets and internal use software, the allowance for doubtful accounts, and goodwill impairment testing; the assumptions used to calculate stock-based compensation; and the realization of deferred tax assets. The Company bases its estimates on past experience, market conditions, and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the first quarter of 2020, the COVID-19 pandemic has negatively impacted, and may continue to negatively impact, the macroeconomic environment in the U.S. and globally, as well as the Company’s business, financial condition and results of operations. In the quarters subsequent to the second quarter of 2020, the underlying demand for the Company’s services has stabilized. Due to the evolving and uncertain nature of COVID-19, it is reasonably possible that it could still materially impact the Company’s estimates, particularly those noted above that require consideration of forecasted financial information, in the near to medium term. The ultimate impact of the COVID-19 pandemic will depend on numerous evolving factors that the Company may not be able to accurately predict, including the duration of the pandemic, new variants and their effects, vaccination rates and effectiveness, the impact of federal, state, local and foreign governmental actions, consumer behavior in response to the pandemic, macro-economic effects, such as supply chain constraints, labor shortages and inflationary pressures, and other economic and operational conditions the Company may face.</span></div>
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63777000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51734000 USD
CY2021Q3 us-gaap Restricted Cash Equivalents Current
RestrictedCashEquivalentsCurrent
213000 USD
CY2020Q4 us-gaap Restricted Cash Equivalents Current
RestrictedCashEquivalentsCurrent
187000 USD
CY2021Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
2701000 USD
CY2020Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
2800000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66691000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54721000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4257000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5843000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
764000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1647000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
640000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1975000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4381000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5515000 USD
CY2020Q3 us-gaap Share Price
SharePrice
2.29
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
7233000 USD
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12378000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11840000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10961000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9597000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1417000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2243000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
418000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
733000 USD
us-gaap Depreciation
Depreciation
1378000 USD
us-gaap Depreciation
Depreciation
2401000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-527000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
452692000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
187389000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
265303000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
392948000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
149600000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
243348000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13596000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14498000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37927000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43514000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
458586000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
191721000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
649780000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9700000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8808000 USD
CY2021Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4526000 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3482000 USD
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1844000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2503000 USD
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
19000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
4277000 USD
CY2021Q3 ias Accrued Bonuses And Commissions Current
AccruedBonusesAndCommissionsCurrent
10013000 USD
CY2020Q4 ias Accrued Bonuses And Commissions Current
AccruedBonusesAndCommissionsCurrent
11883000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
38789000 USD
CY2021Q3 ias Accrued Revenue Sharing Current
AccruedRevenueSharingCurrent
5823000 USD
CY2020Q4 ias Accrued Revenue Sharing Current
AccruedRevenueSharingCurrent
2503000 USD
CY2021Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
6464000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3019000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4710000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2314000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43099000 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2318000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
4468000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
232682000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
351071000 USD
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
337000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
19373000 USD
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
341000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1020000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1024000 USD
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
5417000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
6320000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
16464000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
235000000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
235000000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-898000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1486000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.084
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4855000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10616000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.093
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.231
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8141000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49673000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 USD
CY2021Q3 us-gaap Capital Leases Future Minimum Payments Net Minimum Payments1
CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1
50000 USD
CY2021Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
0 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1883000 USD
CY2021Q3 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
50000 USD
CY2021Q3 us-gaap Purchase Obligation
PurchaseObligation
57500000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1933000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
5594000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
6107000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9780000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4448000 USD
us-gaap Net Income Loss
NetIncomeLoss
-47615000 USD
us-gaap Net Income Loss
NetIncomeLoss
-35343000 USD
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151988054 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151988054 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134039202 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134039202 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140016260 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140016260 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134047188 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134047188 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8913680 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5285887 shares

Files In Submission

Name View Source Status
0001842718-21-000009-index-headers.html Edgar Link pending
0001842718-21-000009-index.html Edgar Link pending
0001842718-21-000009.txt Edgar Link pending
0001842718-21-000009-xbrl.zip Edgar Link pending
ex-3111.htm Edgar Link pending
ex-3121.htm Edgar Link pending
ex-3211.htm Edgar Link pending
ex-3221.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ias-20210930.htm Edgar Link pending
ias-20210930.xsd Edgar Link pending
ias-20210930_cal.xml Edgar Link unprocessable
ias-20210930_def.xml Edgar Link unprocessable
ias-20210930_g1.jpg Edgar Link pending
ias-20210930_htm.xml Edgar Link completed
ias-20210930_lab.xml Edgar Link unprocessable
ias-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending